drugset / Trial / NCT01602367

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

NCT01602367 ↗

Phase 2 Terminated 7 enrolled Bristol-Myers Squibb
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether BMS-823778 is safe and effective in the treatment of hypertension in overweight and obese patients.

Timeline

Start
2012-07
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-823778 Small molecule 2 mg Oral
Subject BMS-823778 Small molecule 6 mg Oral
Subject BMS-823778 Small molecule 15 mg Oral

Indications